Glucosylceramide Synthase Inhibitors [MoA] - N0000020019

Pharmacologic Class Information

Pharmacologic Code N0000020019
Pharmacologic Name Glucosylceramide Synthase Inhibitors
Pharmacologic Uses
  • glucosylceramide synthase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Glucosylceramide Synthase Inhibitors

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Glucosylceramide Synthase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
10148-201Miglustat Non-Proprietary Name: MiglustatCapsuleOralCotherix, Inc.ACTIVE
42799-709Yargesa Non-Proprietary Name: MiglustatCapsuleOralEdenbridge Pharmaceuticals Llc.ACTIVE
43975-310Miglustat Non-Proprietary Name: MiglustatCapsuleOralAni Pharmaceuticals, Inc.ACTIVE
58468-0220Cerdelga Non-Proprietary Name: EliglustatCapsuleOralGenzyme CorporationACTIVE
66215-201Zavesca Non-Proprietary Name: MiglustatCapsuleOralActelion Pharmaceuticals Us, Inc.ACTIVE
71904-300Opfolda Non-Proprietary Name: MiglustatCapsuleOralAmicus Therapeutics Us, LlcACTIVE